85 related articles for article (PubMed ID: 3491138)
1. Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound.
Camp RD; Fincham NJ; Cunningham FM; Greaves MW; Morris J; Chu A
J Immunol; 1986 Dec; 137(11):3469-74. PubMed ID: 3491138
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil chemoattractant and IL-1-like activity in samples from psoriatic skin lesions. Further characterization.
Fincham NJ; Camp RD; Gearing AJ; Bird CR; Cunningham FM
J Immunol; 1988 Jun; 140(12):4294-9. PubMed ID: 3286771
[TBL] [Abstract][Full Text] [Related]
3. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
Takematsu H; Tagami H
Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
[TBL] [Abstract][Full Text] [Related]
4. Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses.
Takematsu H; Terui T; Ohkohchi K; Tagami H; Suzuki R; Kumagai K
Acta Derm Venereol; 1986; 66(2):93-7. PubMed ID: 2424251
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene B4-like material in scale of psoriatic skin lesions.
Brain SD; Camp RD; Cunningham FM; Dowd PM; Greaves MW; Black AK
Br J Pharmacol; 1984 Sep; 83(1):313-7. PubMed ID: 6091827
[TBL] [Abstract][Full Text] [Related]
6. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.
Brain S; Camp R; Dowd P; Black AK; Greaves M
J Invest Dermatol; 1984 Jul; 83(1):70-3. PubMed ID: 6330213
[TBL] [Abstract][Full Text] [Related]
7. Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant eicosanoids.
Camp RD; Cunningham FM; Fincham NJ; Greaves MW; Kobza Black A; Mallet AI; Woollard PM
Br J Pharmacol; 1988 Aug; 94(4):1043-50. PubMed ID: 3061542
[TBL] [Abstract][Full Text] [Related]
8. Biologically active, alternatively processed interleukin-1 beta in psoriatic scales.
Lundqvist EN; Egelrud T
Eur J Immunol; 1997 Sep; 27(9):2165-71. PubMed ID: 9341755
[TBL] [Abstract][Full Text] [Related]
9. Polypeptide neutrophil chemoattractants in the skin.
Camp RD
Dermatologica; 1989; 179 Suppl 1():20-4. PubMed ID: 2673854
[TBL] [Abstract][Full Text] [Related]
10. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
[TBL] [Abstract][Full Text] [Related]
11. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
12. Effect of zinc therapy on neutrophil chemotaxis in psoriasis.
Leibovici V; Statter M; Weinrauch L; Tzfoni E; Matzner Y
Isr J Med Sci; 1990 Jun; 26(6):306-9. PubMed ID: 2380030
[TBL] [Abstract][Full Text] [Related]
13. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
[TBL] [Abstract][Full Text] [Related]
14. The identification of hydroxy fatty acids in psoriatic skin.
Camp RD; Mallet AI; Woollard PM; Brain SD; Black AK; Greaves MW
Prostaglandins; 1983 Sep; 26(3):431-47. PubMed ID: 6419288
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotaxis in psoriasis.
Wahba A; Cohen H; Bar-Eli M; Callily R
Acta Derm Venereol; 1979; 59(5):441-5. PubMed ID: 93368
[TBL] [Abstract][Full Text] [Related]
16. Chemokinetic and chemotactic factors in psoriasis scale extracts.
Dahl MV; Lindroos WE; Nelson RD
J Invest Dermatol; 1978 Dec; 71(6):402-6. PubMed ID: 722120
[TBL] [Abstract][Full Text] [Related]
17. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients.
Teran LM; Campos MG; Begishvilli BT; Schröder JM; Djukanovic R; Shute JK; Church MK; Holgate ST; Davies DE
Clin Exp Allergy; 1997 Apr; 27(4):396-405. PubMed ID: 9146932
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in skin lesions of psoriasis.
Gearing AJ; Fincham NJ; Bird CR; Wadhwa M; Meager A; Cartwright JE; Camp RD
Cytokine; 1990 Jan; 2(1):68-75. PubMed ID: 2104215
[TBL] [Abstract][Full Text] [Related]
19. [Neutrophil granulocyte chemotaxis and psoriasis].
Christophers E; Schröder JM
Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
[TBL] [Abstract][Full Text] [Related]
20. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
Horrocks C; Holder JE; Berth-Jones J; Camp RD
Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
